Alcon (SIX/NYSE: ALC), the global leader in eye care, dedicated to helping people see brilliantly, announced today the full U ...

In this Healio Video Perspective from Telling It Like It Is, I. Paul Singh, MD, discusses utilizing the “robust” portfolio of ...

At the Envision Summit 2025 in San Juan, Puerto Rico, Rachel Simpson, MD, talked about new developments in glaucoma treatment ...

The focus in recent years has shifted to reducing the long-term burden of medical therapy, minimizing the risk of medication ...

Despite only being 32, identical twins Gemma and Stella have been diagnosed with the vision loss condition glaucoma ...

Glaucoma affects an estimated 4.2 million people in the United States and is often called the silent thief of sight because ...

Learn about glaucoma, a leading cause of blindness, its types, symptoms, risk factors, and treatment options for prevention.

Aster Hospital Al Qusais, recognized in Newsweek's“World's Best Smart Hospitals 2025” List among 350 hospitals globally and ...

It is important to look for specific signs of vision loss in children, and be proactive about routine visits to an eye ...

What started as a ‘friendly conversation’ on the UNTHSC campus could lead to a breakthrough in treating glaucoma—the leading ...

Alcon (ALC) announced he full U.S. commercial availability of Voyager DSLT, the first and only Direct Selective Laser Trabeculoplasty device .

Voyager DSLT has been embraced by my staff and is easy to implement, allowing me to treat more of my patients with a recognized first-line standard in glaucoma treatment.” Glaucoma is a ...